Brief: Scope Fluidics Says Bacteromic Project Gets Validation Under First Preregistration Tests
30/09/2021 17:52
Sept 30 (Reuters) - Scope Fluidics SA SCPP.WA :
* BACTEROMIC PROJECT GETS VALIDATION UNDER FIRST
PREREGISTRATION
TESTS
* RESULTS GIVE BASIS FOR APPLYING TO POLAND'S MEDICINE
AUTHORITY
FOR REGISTERING BACTEROMIC AS MEDICAL PRODUCT FOR IN VITRO
DIAGNOSTICS
* COMPANY WILL BE CONTINUE FURTHER RESEARCH AND DEVELOPMENT
FOR
BACTEROMIC
Source text for Eikon: ID:nEM7zS0sRa
Further company coverage: SCPP.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Scope Fluidics SA
See all newsBrief: Scope Fluidics' EDOCERA Project Meets Second Goal Of Developing Prototype Of Device For Detecting Stroke Symptoms
Brief: Scope Fluidics Q2 Net Loss At 10.1 Million Zlotys
Brief: Scope Fluidics Unit Signs Deal With Poland's PARP For Up To 14.4 Mln Zlotys In Funding For HYBOLIC Project
Brief: Scope Fluidics Says FDA Certification For UNI FAST Panel Planned For Second Half Of 2027
Brief: Scope Fluidics Extends Deadline For First Goal In Hybolic Project